» Articles » PMID: 11714939

Typing of Chlamydia Trachomatis Strains from Urine Samples by Amplification and Sequencing the Major Outer Membrane Protein Gene (omp1)

Overview
Date 2001 Nov 21
PMID 11714939
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To develop a novel protocol for the extraction, amplification, and sequencing of Chlamydia trachomatis MOMP gene (omp1) from urine, a non-invasive source, and apply it to an epidemiological study on the distribution of C trachomatis strains in a population of pregnant women in Thailand.

Methods: The C trachomatis DNA was extracted from culture stocks and urine using a slightly modified commercially available kit, the High Pure PCR Template Preparation Kit (Roche Molecular Biochemicals, IN, USA). The PCR and sequencing primers used for the amplification and sequencing of the omp1 were designed based on the nucleotide sequence of multiple C trachomatis strains found in GenBank. The protocol for the extraction, amplification, and sequencing was tested on laboratory culture stocks of reference strains of all C trachomatis serovars and on urine samples collected in a cross sectional study designed to assess the prevalence of C trachomatis infections in the cities of Bangkok and Chiang Rai, Thailand.

Results: The omp1 gene was successfully amplified and sequenced from 18 laboratory C trachomatis reference strains and from 45 C trachomatis positive urine clinical samples collected from asymptomatic pregnant women. Among clinical samples, we found nine different C trachomatis genotypes: F (11, 25%), D (10, 22.6%), H (5, 11.7%), K (5, 11.7%), E (4, 9.3%), Ia (3, 7%), B (3, 7%), Ja (2, 4.5%), and G (1, 2.3%). One specimen generated an omp1 DNA sequence pattern indicating the presence of a mixed infection with at least two different serovars.

Conclusions: Urine is a convenient and reliable source for genotyping C trachomatis strains. A clear advantage of urine over traditional samples, such as cervical swabs, is that urine is a non-invasive source which makes collection easier and thus facilitates the enrolment of patients in clinical and epidemiological studies. In addition to typing, urine is increasingly used for diagnosis of C trachomatis infection by several commercially available nucleic acid amplification assays which represents a distinct advantage for collecting, transport, storage, and laboratory handling of samples.

Citing Articles

Ensuring equity with pre-clinical planning for chlamydia vaccines.

Collar A, Clarke T, Jamus A, Frietze K NPJ Vaccines. 2023; 8(1):131.

PMID: 37673890 PMC: 10482967. DOI: 10.1038/s41541-023-00726-7.


Distribution of A genotypes in patients attending a sexually transmitted disease outpatient clinic in New Delhi, India.

Rawre J, Dhawan B, Khanna N, Sreenivas V, Broor S, Chaudhry R Indian J Med Res. 2019; 149(5):662-670.

PMID: 31417035 PMC: 6702700. DOI: 10.4103/ijmr.IJMR_1171_17.


Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.

Wilson N, Goodhew B, Mkocha H, Joseph K, Bandea C, Black C Ophthalmic Epidemiol. 2018; 26(1):1-6.

PMID: 30543311 PMC: 6352373. DOI: 10.1080/09286586.2017.1293693.


Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Sahu R, Verma R, Dixit S, Igietseme J, Black C, Duncan S Expert Rev Vaccines. 2018; 17(3):217-227.

PMID: 29382248 PMC: 6330895. DOI: 10.1080/14760584.2018.1435279.


Genome sequencing of Chlamydia trachomatis serovars E and F reveals substantial genetic variation.

Eder T, Kobus S, Stallmann S, Stepanow S, Kohrer K, Hegemann J Pathog Dis. 2017; 75(9).

PMID: 29186396 PMC: 5827700. DOI: 10.1093/femspd/ftx120.


References
1.
Ikehata M, Numazaki K, Chiba S . Analysis of Chlamydia trachomatis serovars in endocervical specimens derived from pregnant Japanese women. FEMS Immunol Med Microbiol. 2000; 27(1):35-41. DOI: 10.1111/j.1574-695X.2000.tb01409.x. View

2.
GRAYSTON J, Wang S . The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis. 1978; 5(2):73-7. DOI: 10.1097/00007435-197804000-00011. View

3.
Wang S, Kuo C, BARNES R, Stephens R, GRAYSTON J . Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis. 1985; 152(4):791-800. DOI: 10.1093/infdis/152.4.791. View

4.
Stephens R, Wagar E, Inouye C, Urdea M . Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol. 1987; 169(9):3879-85. PMC: 213681. DOI: 10.1128/jb.169.9.3879-3885.1987. View

5.
Yuan Y, Zhang Y, Watkins N, Caldwell H . Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun. 1989; 57(4):1040-9. PMC: 313226. DOI: 10.1128/iai.57.4.1040-1049.1989. View